Multiple Fluorometric Assay of Three Major Vitamin D3 Metabolites (25-Hydroxyvitamin D3, 24,25-Dihydroxyvitamin D3 and 1,25-Dihydroxyvitamin D3) in Plasma and Its Application to Clinical Studies.

  • WANG Xinxiang
    Institute for Medical and Dental Engineering and Third Department of
  • SHIMIZU Masato
    Institute for Medical and Dental Engineering and Third Department of
  • NUMANO Fujio
    Institute for Medical and Dental Engineering and Third Department of
  • ASAOKA Hiroshi
    Institute for Medical and Dental Engineering and Third Department of
  • YAMADA Sachiko
    Institute for Medical and Dental Engineering and Third Department of

Bibliographic Information

Other Title
  • Multiple Fluorometric Assay of Three Ma

Search this article

Abstract

We have developed a fluorometric method for routine analyses of 25-hydroxyvitamin D3 (25-OHD3) and 24, 25- and 1, 25-dihydroxyvitamin D3 [24, 25- and 1, 25-(OH)2D3] in human plasma. Lipid extracts from plasma (2.5ml) were purified using a Sep-Pak silica cartridge followed by normal-phase HPLC, and each of the three metabolites was assayed in separate lines. Each metabolite fraction was treated with fluorescent dienophile (DMEQ-TAD) and quantified on reversed-phase HPLC after appropriate cleanup steps. Labeled 25-OHD3 was quantified directly, 24, 25-(OH)2D3 was analyzed after cleanup by a Bond Elut PSA cartridge and 1, 25-(OH)2D3 was quantified after purification by a Bond Elut PSA cartridge and normal-phase HPLC. In the assay of 25-OHD3, we demonstrated the usefulness of a non-radioactive internal standard for the fluorometric assay. The multiple fluorometric assay was successfully applied to the clinical monitoring of vitamin D3 therapy in a vitamin D-deficient patient with metabolic bone disease.

Journal

  • Analytical Sciences

    Analytical Sciences 13 (2), 255-261, 1997

    The Japan Society for Analytical Chemistry

Citations (3)*help

See more

References(52)*help

See more

Details 詳細情報について

Report a problem

Back to top